iRhythm Executive Plans $140K Stock Sale Following $1M Recent Dispositions

iRhythm Technologies (NASDAQ: IRTC) has filed a Form 144 notice for a proposed sale of securities by an insider.

Rhea-AI Filing Summary

iRhythm Technologies (NASDAQ: IRTC) has filed a Form 144 notice for a proposed sale of securities by an insider. The filing details planned sales of 936 shares of common stock with an aggregate market value of $140,400, to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange around June 23, 2025.

The securities were originally acquired as Restricted Stock from the issuer on March 1, 2025. The selling party, Chad Patterson, has conducted several previous transactions in the past 3 months totaling:

• 363 shares sold on June 10, 2025 ($54,450)
• 8,510 shares sold on May 2, 2025 ($1,025,897.50)

The total outstanding shares of iRhythm Technologies are reported at 31,925,267. This Form 144 filing indicates the seller's representation that they are not aware of any material adverse non-public information regarding the company's operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many IRTC shares is the insider planning to sell according to the June 2025 Form 144?

According to the Form 144 filing, the insider plans to sell 936 shares of IRTC common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $140,400.00.

Who is selling IRTC shares and what is their recent trading history?

Chad Patterson, located at 699 8th Street, Suite 600, San Francisco CA, is the seller. In the past 3 months, Patterson has made several sales: 363 shares on June 10, 2025 ($54,450), and four separate transactions on May 2, 2025 totaling 8,510 shares with combined proceeds of approximately $1.026 million.

What is the source of IRTC shares being sold in this Form 144?

The shares being sold were acquired as Restricted Stock from the issuer (IRTC) on March 1, 2025. The filing indicates 936 shares were acquired on that date, and payment was listed as 'Not Applicable' as these were restricted stock grants.

What is IRTC's total shares outstanding according to the June 2025 Form 144?

According to the Form 144 filing, iRhythm Technologies (IRTC) has 31,925,267 shares outstanding as of the filing date.

When does the insider plan to execute the IRTC stock sale?

According to the Form 144 filing, the approximate date of sale is listed as June 23, 2025, and the shares will be sold on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2025 - 04:13 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001850152
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IRHYTHM TECHNOLOGIES, INC.
SEC File Number	001-37918
Address of Issuer	699 8th Street Suite 600 San Francisco CALIFORNIA 94103
Phone	(415) 632-5700
Name of Person for Whose Account the Securities are To Be Sold	CHAD PATTERSON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	936	140400.00	31925267	06/23/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2025	Restricted Stock	ISSUER			936	03/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHAD PATTERSON 699 8th Street Suite 600 San Francisco CA 94103	Common	06/10/2025	363	54450.00
CHAD PATTERSON 699 8th Street Suite 600 San Francisco CA 94103	Common	05/02/2025	1300	162500.00
CHAD PATTERSON 699 8th Street Suite 600 San Francisco CA 94103	Common	05/02/2025	1592	190642.00
CHAD PATTERSON 699 8th Street Suite 600 San Francisco CA 94103	Common	05/02/2025	3367	403198.25
CHAD PATTERSON 699 8th Street Suite 600 San Francisco CA 94103	Common	05/02/2025	2251	269557.25

144: Remarks and Signature

Remarks
Date of Notice	06/23/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Chad Michael Patterson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)